shire.com
Shire Newsroom: Media, News & Press Releases
https://www.shire.com/newsroom
Annual and Interim Reports. Annual and Interim Reports. Excellence in ADHD Patient Group Awards 2016. RESEARCH AND EDUCATIONAL GRANTS. Thursday, September 1, 2016. Filter by: All Press Releases. Sort By: Most Recent. Sort By: A to Z. Sort By: Z to A. Head of Communications and Public Affairs. Communications and Public Affairs. Communications and Public Affairs. Communications and Public Affairs. For Marketed Product and Pipeline Inquiries. Communications and Public Affairs. For All International Inquiries.
alliance-maladies-rares.org
Une arrivée dans l’équipe permanente de l’Alliance - Alliance Maladies Rares
http://www.alliance-maladies-rares.org/une-arrivee-dans-lequipe-permanente-de-lalliance
Aller au contenu primaire. Vous êtes ici :. 01 - Actualités générales et Agenda. Une arrivée dans l’équipe permanente de l’Alliance. Une arrivée dans l’équipe permanente de l’Alliance. Elisabeth Célestin a rejoint l’équipe permanente de l’Alliance Maladies Rares le 20 avril,en tant qu’. Assistante Information et Communication. Elisabeth a une longue expérience de ces sujets et connaît bien l’Alliance et les maladies rares pour avoir été active pendant plusieurs années au sein d’une association membre.
alliance-maladies-rares.org
Les Régates Extraordinaires de l'Alliance Maladies Rares - Alliance Maladies Rares
http://www.alliance-maladies-rares.org/agenda/save-the-date-les-regates-extraordinaires-de-lalliance-maladies-rares
Aller au contenu primaire. Les Régates Extraordinaires de l’Alliance Maladies Rares. Vous êtes ici :. Les Régates Extraordinaires de l’Alliance Maladies Rares. Les Régates Extraordinaires de l’Alliance Maladies Rares. Le 11 et 12 juillet 2015. Le week-end du 11 et 12 juillet 2015 aura lieu la 1ère édition des Régates Extraordinaires. Pour cette 1ère édition, 5 régions se lancent dans l’aventure avec le soutien des associations et collectivités locales. Au Port de Carentan en région Basse-Normandie (50).
investors.shire.com
Shire: E-communications
http://investors.shire.com/shareholder-information/e-communications.aspx
Skip to main content. Annual and Interim Reports. Annual and Interim Reports. Excellence in ADHD Patient Group Awards 2016. RESEARCH AND EDUCATIONAL GRANTS. Annual and Interim Reports. Shire proposed combination with Baxalta. Research and Development day. Annual and Interim Reports. Shire proposed combination with Baxalta. Research and Development day. Electronic and Printed Communications – Making Your Choice. To do this you must register free at http:/ www.shareview.co.uk. Shire's electronic communicat...
investors.shire.com
Shire: Financial Highlights
http://investors.shire.com/financial-highlights.aspx
Skip to main content. Annual and Interim Reports. Annual and Interim Reports. Excellence in ADHD Patient Group Awards 2016. RESEARCH AND EDUCATIONAL GRANTS. Annual and Interim Reports. Shire proposed combination with Baxalta. Research and Development day. Annual and Interim Reports. Shire proposed combination with Baxalta. Research and Development day. Non GAAP adjusted ROIC. Non GAAP cash generation. Non GAAP EBITDA margin. Non GAAP operating income. This is a Non GAAP financial measure. Learn more abou...
shire.com
About Shire: Business Development & Partnerships
https://www.shire.com/who-we-are/how-we-operate/partnerships
Annual and Interim Reports. Annual and Interim Reports. Excellence in ADHD Patient Group Awards 2016. RESEARCH AND EDUCATIONAL GRANTS. A CLEAR AND FOCUSED BUSINESS DEVELOPMENT STRATEGY. We are constantly seeking out new innovation opportunities through strategic partnerships, acquisitions and licenses. We strive to bolster our core therapeutic areas and expand into high-value adjacent therapeutic areas to create the most value for our patients, partners and Shire. WHY PARTNER WITH SHIRE? By following thi...
rare2015.com
Rare 2015 - Les maladies rares : Quelles attentes et quels enjeux pour la société ?
http://www.rare2015.com/index.php
PRà SENTATIONS INTERVENANTS 2015. Laquo; Les maladies rares : quelles attentes et quels enjeux pour la société? Christian DELEUZE, Président - Genzyme SAS and Polyclonals. Pr Didier LACOMBE, Fédération Française de Génétique Humaine. Tel : 04 67 64 01 75. Tel : 01 44 64 14 77. Ils témoignent sur RARE 2013. Suivez RARE 2015 sur les rà seaux sociaux :. 03 Mars 2015 : Ouverture des inscriptions. 17 Mars 2015: Ouverture de la soumission des posters. Avec le soutien de.
shire.co.kr
Shire 정보: 당사 이력
http://www.shire.co.kr/who-we-are/our-story/our-history
환우 단체 지원 정보. 연구 및 교육 지원. Shire의 역사는 소규모 기업들이 당시 충족되지 못한 의료 요구에 대한 해결책을 강구하던 1986년으로 거슬러 올라갑니다. 초기 2년의 운영기간 동안 당사는 골다공증을 치료하고 예방하기 위해 다양한 칼슘보충제를 판매 시작하였습니다. 이후 알츠하이머병 및 말기 신부전과 같은 험난한 질환을 직면한 환자들을 위한 혁신적인 약물개발을 위한 프로그램을 진행하였습니다. 2016년 6월, Shire는 Baxalta와의 합병을 통해 희귀질환 및 특수한 질환으로 고통 받는 이들을 위한 일에 초점을 맞춘 선도적인 글로벌 생명공학 기업으로 거듭났습니다. 전세계 100여국의 22,000여명의 Shire 직원들은 충족되지 못한 의료 요구를 가진 환자들을 돕고자 Shire의 영향력을 확대 시키고 최고 수준의 제품을 공급하기 위해 노력하고 있습니다. 지속 가능한 100대 글로벌 기업에 선정된 Shire. Email 또는 SMS 알림 수신 서명.
